Cited by 467Neuroscience and Neuropharmacology ResearchNeurotransmitter Receptor Influence on BehaviorDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

Di Chiara, Gaetano, Morelli, Micaela, Consolo, Silvana·1994·Trends in Neurosciences

DOI 10.1016/0166-2236(94)90005-1

Open this paper in CoChat — free account

Abstract

The striatum is viewed as a structure performing fast neurotransmitter-mediated operations through somatotopically organized projections to medium-size spiny neurons. This view is contrasted with another view that depicts the striatum as a site of diffuse modulatory influences mediated by cholinergic interneurons and by dopamine and N-methyl-D-aspartate receptors. These two operational and organizational modes both contribute, through their mutual interaction, to the function of basal ganglia. Detailed knowledge of the neural mechanisms by which such interactions take place and are expressed into behaviour, can provide new insight into the physiopathology and new clues for therapy of disorders of basal ganglia.

Integrity signals

Registry

Crossref · 10.1016/0166-2236(94)90005-1

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Parallel organization of functionally segregated circuits linking basal ganglia and cortex
Alexander, G. E., DeLong, M. R., & Strick, P. L. (1986) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.09.030186.002041 · Cited by 8,527
The functional anatomy of basal ganglia disorders
Albin, R. L., Young, A. B., & Penney, J. B. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90074-x · Cited by 5,353
The Synaptic Organization of the Brain
(2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195159561.001.1 · Cited by 3,574
D 1 and D 2 Dopamine Receptor-regulated Gene Expression of Striatonigral and Striatopallidal Neurons
Gerfen, C. R., Engber, T. M., Mahan, L. C., Susel, Z., Chase, T. N., Monsma, F. J., & Sibley, D. R. (1990) · Science · doi:10.1126/science.2147780 · Cited by 2,967
Brain dopamine receptors.
Seeman, P. M. (1980) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06839-5 · Cited by 1,888
Neurotransmitters and neuromodulators in the basal ganglia
Graybiel, A. M. (1990) · Trends in Neurosciences · doi:10.1016/0166-2236(90)90104-i · Cited by 1,576
The neostriatal mosaic: multiple levels of compartmental organization
Gerfen, C. R. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90355-c · Cited by 1,471
Muscarinic Receptor Subtypes
Hulme, E. C., Birdsall, N. J. M., & Buckley, N. J. (1990) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.30.040190.003221 · Cited by 1,366
The mysterious motor function of the basal ganglia
MARSDEN, C. D. (1982) · Neurology · doi:10.1212/wnl.32.5.514 · Cited by 924
SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.
Iorio, L. C., Barnett, A., Leitz, F. H., Houser, V. P., & Korduba, C. A. (1983) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21599-3 · Cited by 896

Show all 72 references

Research works printed but not linked: 17

Kitai, 1993, Adv. Neurol., 60, 40
Herrling, 1992, Arzneimit. Forsch. Drug Res., 42, 202
Morelli, 1992, J. Pharmacol. Exp. Ther., 260, 402
Meredithy, 1990, Neurology, 296, 204
Kimura, 1984, 81, 4998
Maura, 1988, J. Pharmacol. Exp. Ther., 247, 680
Jarvie, 1993, Adv. Neurol., 60, 325
Iorio, 1983, J. Pharmacol. Exp. Ther., 226, 462
Damsma, 1991, J. Pharmacol. Exp. Ther., 259, 1064
Imperato, 1993, J. Pharmacol. Exp. Ther., 366, 557
Meller, 1987, Mol. Pharmacol., 31, 592
Seeman, 1981, Pharmacol. Rev., 32, 229
Le Moine, 1990, 87, 230
Le Moine, 1991, 88, 4205
Di Chiara G.; Morelli M. Basal Ganglia IV, Proc. IVth Meeting Int. Basal Ganglia Society Percheron G.; McKenzie J.S. Plenum Press (in press.)
Di Chiara, 1993, Adv. Neurol., 60, 102
Riederer, 1993, Adv. Neurol., 60, 626

Sorted by citations

Items 401–467 of 467

Clinical syndromes of neurotransmitter system dysfunction in severe brain injury
Александрова, Е. В., Zaytsev, O. S., & Aa, P. (2015) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro20151157140-46 · Cited by 5
Inhibition of basal and amphetamine-stimulated extracellular signal-regulated kinase (ERK) phosphorylation in the rat forebrain by muscarinic acetylcholine M4 receptors
He, N., Mao, L., Sturich, A. W., Jin, D.-Z., & Wang, J. Q. (2018) · Brain Research · doi:10.1016/j.brainres.2018.03.019 · Cited by 5
Functional organization of the dorsal striatum : comparison to the hippocampal system
Devan, B. D. (1997) · Library and Archives Canada (Government of Canada) · doi:10.82308/2143 · Cited by 5
Imidazoline I1 receptor-mediated reduction of muscle rigidity in the reserpine-treated murine model of Parkinson's disease
Tanabe, M., Hashimoto, M., & Ono, H. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.06.013 · Cited by 4
POSITIVE ALLOSTERIC MODULATION OF mGlur4 RECEPTORS AS A POTENTIAL APPROACH TO THE TREATMENT OF PARKINSON'S DISEASE
Авдеева, Н. В., Sa, S., Povetkin, S. V., Жернакова, Н. И., & Сернов, Л. Н. (2018) · University proceedings Volga region Medical sciences · doi:10.21685/2072-3032-2018-3-18 · Cited by 4
Drugs of Abuse and Striatal Gene Expression
McGinty, J. F., & Wang, J. Q. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60920-5 · Cited by 4
Case Report: Delusional Jealousy Following Right-Sided Cerebral Infarct
Wong, A. H. C., & Meier, H. (1997) · Neurocase · doi:10.1080/13554799708411978 · Cited by 4
The biochemistry of Tourette's Syndrome
Chokka, P. R., Baker, G. B., Bornstein, R. A., & de Groot, C. M. (1995) · Metabolic Brain Disease · doi:10.1007/bf01991859 · Cited by 4
Long-term neuroleptic treatments counteract dopamine D2 agonist inhibition of adenylate cyclase but do not affect pertussis toxin ADP-ribosylation in the rat brain
Okada, F., Ito, A., Horikawa, T., Tokumitsu, Y., & Nomura, Y. (1996) · Neurochemistry International · doi:10.1016/0197-0186(95)00074-7 · Cited by 4
Muscarinic Acetylcholine Receptors
Wess, J. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn005 · Cited by 4
Cholinergic modulation of reinforcement learning and prefrontal value computations under uncertaintyPreprint
Kurtenbach, H., Froböse, M. I., Ort, E., Bahners, B. H., Butz, M., Schnitzler, A., Hirschmann, J., & Jocham, G. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.09.20.614105 · Cited by 4
Histaminergic H 2 receptor ligands modulate acetylcholine release in the ventral striatum
Philippu, A., Tran, M. H., & Prast, H. (1999) · Inflammation Research · doi:10.1007/s000110050402 · Cited by 3
A free-choice high-fat diet modulates the effects of a sucrose bolus on the expression of genes involved in glucose handling in the hypothalamus and nucleus accumbens.
Koekkoek, L. L., Unmehopa, U. A., Eggels, L., Kool, T., Lamuadni, K., Diepenbroek, C., Mul, J. D., Serlie, M. J. M., & la Fleur, S. E. (2020) · Physiology & Behavior · doi:10.1016/j.physbeh.2020.112936 · Cited by 3
Regulation of Gene Expression by Muscarinic Acetylcholine Receptors: A Comprehensive Approach for the Identification of Regulated Genes
von der Kammer, H., Mayhaus, M., Albrecht, C., Andresen, B., Klaudiny, J., Demiralay, C., & Nitsch, R. M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06939.x · Cited by 3
ROLES OF .MU.-OPIOID RECEPTORS IN DEVELOPMENT OF TOLERANCE TO DIISOPROPYLFLUOROPHOSPHATE (DFP)
Tien, L., Fan, L.-W., Ma, T., Loh, H. H., & Ho, I. K. (2005) · The Journal of Toxicological Sciences · doi:10.2131/jts.30.43 · Cited by 3
Effects of Cholecystokinin Agonists on Striatal Neurons are Reduced by Acetylcholine
Davidowa, H., Wetzel, K., & Vierig, G. (1997) · Peptides · doi:10.1016/s0196-9781(97)00054-5 · Cited by 3
Pontine reticular formation is involved in catalepsy produced by cholinergic drugs
Elazar, Z., Ganchrow, D., & Paz, M. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005037 · Cited by 3
The Role of Striatal Glutamatergic System in Haloperidol-Induced Dopamine Receptor Supersensitivity and Effects of Monosialoganglioside GM1
Schröeder, H., Schröeder, U., & Sabel, B. A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00026-9 · Cited by 3
Nicotinic Involvement in Cognitive Function of Rats
Levin, E. D. (2001) · CRC Press eBooks · doi:10.1201/9781420038521-15 · Cited by 3
STUDY OF RAPITALAM INFLUENCE ON OXOTREMORINE-INDUCED TREMOR
Авдеева, Н. В. (2019) · Pharmacy & Pharmacology · doi:10.19163/2307-9266-2019-7-2-84-89 · Cited by 2
Estudio funcional del receptor dopaminérgico D2 en el sistema nervioso central mediante el uso de ratones mutantes inducibles
del Pilar, E. (2012) · Cited by 2
6-Hydroxydopamine Lesioning of Dopamine Neurons in Neonatal and Adult Rats Induces Age-Dependent Consequences
Papadeas, S. T., & Breese, G. R. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_59 · Cited by 2
M1 Muscarinic Receptor Stimulation Decreases Aspartate Release in the Rat Neostriatum
Expósito, I., Sanz‐Barbero, B., & Mora, F. (1997) · Neurochemical Research · doi:10.1023/a:1021906529055 · Cited by 2
STUDIES OF THE EFFECTS OF DOPAMINE NEURON STIMULATING PEPTIDES IN RODENT MODELS OF NORMAL AND DYSFUNCTIONAL DOPAMINERGIC SYSTEMS
Fuqua, J. L. (2010) · UKnowledge (University of Kentucky) · Cited by 2
Neurobiological Issues in Tourette’s Syndrome
Singer, H. S., & Minzer, K. (2004) · Neurological disease and therapy · doi:10.1201/b14236-15 · Cited by 2
Muscarinic acetylcholine receptor knockout mice: Phenotypical analysis and clinical implications
(2002) · Pharmacochemistry library · doi:10.1016/s0165-7208(02)80012-5 · Cited by 2
G Proteins and Animal Models of Parkinson's Disease
Marcotte, E. R., & Mishra, R. K. (2003) · Humana Press eBooks · doi:10.1385/0-89603-490-9:139 · Cited by 2
Nicotinic Involvement in Cognitive Function of Rats
Rezvani, A. H., & Levin, E. D. (2001) · Frontiers in neuroscience · doi:10.1201/9781420038521.ch7 · Cited by 2
Cellular and Molecular Biology of Neurodevelopment
Zonuzirad, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7433-3_3 · Cited by 2
Glutamatergic Receptors in Parkinson’s Disease
Sampedro, A., Tarragón, E., Yuste, J. E., Ros‐Bernal, F., Ortiz, V., Campuzano, C. M., Gómez, A., Ros, C. M. B., Fernández‐Villalba, E., & Herrero, M. T. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_154 · Cited by 1
Biperiden in the Treatment of Cocaine/Crack Dependence
Ramos, A. C., Dieckmann, L. H. J., & Galduróz, J. C. F. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-803750-8.00066-x · Cited by 1
Non-Dopaminergic Approaches to the Treatment of Parkinson’s Disease
Brotchie, J. M., Maneuf, Y. P., Hughes, N., Duty, S., & Crossman, A. R. (1994) · Advances in behavioral biology · doi:10.1007/978-1-4613-0485-2_57 · Cited by 1
Effect of α-MSH upon cyclic AMP levels induced by the glutamatergic agonists NMDA, quisqualic acid, and kainic acid
de Barioglio, S. R., & Brito, M. I. (1996) · Peptides · doi:10.1016/s0196-9781(96)00229-x · Cited by 1
Protection Against Nigrostriatal Dopamine Cell Death by Pedunculopontine Tegmental Nucleus Lesions
Takada, M., Matsumura, M., Kojima, J., Yamaji, Y., Inase, M., Tokuno, H., Nambu, A., & Imai, H. (2002) · Advances in behavioral biology · doi:10.1007/978-1-4615-0715-4_8 · Cited by 1
Cholinergic modulation of neuronal responses to cholecystokinin in anesthetized rats
Davidowa, H., Wetzel, K., & Vierig, G. (1998) · Brain Research Bulletin · doi:10.1016/s0361-9230(98)00036-7 · Cited by 1
SELECTIVE DELAY ACTIVITY IN THE MEDIAL PREFRONTAL CORTEX: THE CONTRIBUTION OF SENSORY-MOTOR INFORMATION AND EXPECTATION
Cowen, S. L. (2007) · UA Campus Repository (The University of Arizona) · Cited by 1
Changes of Glutamatergic Control of Striatal Acetylcholine Release in Experimental Parkinsonism
Mela, F., Marti, M., Bianchi, C., & Morari, M. (2005) · Springer eBooks · doi:10.1007/0-387-28066-9_10 · Cited by 1
Pesticides and pesticide combinations on brain neurochemistry
Aguilar, C. (2004) · VTechWorks (Virginia Tech) · Cited by 1
Involvement of Cyclin Dependent Kinase 5 in M4 Muscarinic Acetylcholine Receptor-Mediated Cholinergic Transmission within the Mouse Dorsal StriatumPreprint
Zhou, H., Shi, H., Li, X., Zhang, J., Sui, X. Y., Zhao, Z., Nie, Z., Wang, Y., Li, J., & Wang, L. (2021) · Research Square · doi:10.21203/rs.3.rs-290339/v1 · Cited by 1
Amantadin
Kornhuber, J., Wiltfang, J., & Streifler, M. (1999) · Springer eBooks · doi:10.1007/978-3-7091-6400-6_31 · Cited by 1
Non‐Dopaminergic Approaches to the Treatment of Parkinson's Disease
Fox, S. H., & Brotchie, J. M. (2011) · Parkinson s Disease · doi:10.1002/9781444397970.ch38 · Cited by 1
Cholinergic Mechanisms in Schizophrenia
Raedler, T. J., & Freedman, R. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_2 · Cited by 1
Dopamine and the regulation of movements - significance of nigral and striatal dopamine release in normal, hemiparkinsonian and dyskinetic rats
Andersson, D. R. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Identification of inducible genes by activation of muscarinic acetylcholine receptors
von der Kammer, H., Mayhaus, M., Albrecht, C., Hoffmann, B., & Nitsch, R. M. (1998) · Journal of Physiology-Paris · doi:10.1016/s0928-4257(99)80060-6
Effects of Intrastriatal and Systemic Microinjections of Nicotine on Motor Behavior and Its Motor and Postural Components in Dogs
Shapovalova, K. B., & Tikhomirova, P. L. (2011) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-011-9490-x
Una arquitectura neuronal de inspiración biológica para el aprendizaje y control del movimiento de agarre en plataformas robóticas antropomorfas
Molina-Vilaplana, J. (2005) · doi:10.31428/10317/1246
[Drug-craving animal models and mechanisms].
Sakimura, K., Hiranita, T., Miyamoto, M., Nagata, K., & Yamamoto, T. (2005) · Folia Pharmacologica Japonica · doi:10.1254/fpj.126.24
The effect of L-DOPA and natural products on age-related motor deficits and dopaminergic cell survival
Allen, E. N. (2013)
Role of the basal ganglia in conditional associative learning : a multidisciplinary approach
Hadj‐Bouziane, F. (2003) · HAL
Brain muscarinic receptors: lessons from knockout mice
Wess, J. (2006) · CRC Press eBooks · doi:10.1201/b14486-13
Resilient GluN2B-containing NMDARs contribute to dysfunctional synaptic plasticity associated with chronic cocaine intake
deBacker, J. (2012) · QSpace (Queen's University Library)
The effect of vestibular lesions on the hippocampal cholinergic system
Aitken, P. (2017) · Otago University Research Archive (University of Otago)
Targeting muscarinic receptor subtypes as a therapeutic approach in dystonia and Parkinson's disease
Klisko, D. (2017) · Research Portal (King's College London)
Comportamento compulsivo à cocaína e as implicações no sistema colinérgico muscarínico
Spelta, L. E. W. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.9.2017.tde-21112017-155457
The role of sensory history and stimulus context in human time perception. Adaptive and integrative distortions of perceived duration
Fulcher, C. (2017) · Bradford Scholars (University of Bradford)
Experimental Models and New, Emerging Therapies for Parkinson Disease
Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50012-7
IN VIVO STUDY OF THE ACTION MECHANISM OF THE RAPITALAM PHARMACEUTICAL SUBSTANCE
Авдеева, Н. В. (2019) · Кубанский научный медицинский вестник · doi:10.25207/1608-6228-2019-26-1-18-27
Terapia génica anti-inflamatoria en el abordaje de la neurodegeneración dopaminérgica motora
Lockhart, E. F. (2020) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/97168
INFLUÊNCIA DE FÁRMACOS ANTIPSICÓTICOS SOBRE A HIDRÓLISE DE NUCLEOTÍDEOS EXTRACELULARES E ACETILCOLINA EM CÉREBRO DE ZEBRAFISH ( Danio rerio )
Seibt, K. J. (2009) · Americanae (AECID Library)
Muscarinic Acetylcholine Receptors
Nathanson, N. M. (2001) · Wiley eBooks · doi:10.1038/npg.els.0000193
Developing a method for the co-expression and co-localization of muscarinic M4 receptors and dopamine D1 receptors in the mouse brain
Valle-Tojeiro, A. (2022) · doi:10.17760/d20439206
Efficacy of melatonin on mood disorders in cancer and cancer related diseases: A systematic review and meta-analysis of randomized controlled trials
Tharavichitkun, J., Arunmanakul, P., Permsuwan, U., Dilokthornsakul, P., Yadee, J., & Sirichanchuen, B. (2023) · Pharmaceutical Sciences Asia · doi:10.29090/psa.2023.04.23.522
Implication des interneurones cholinergiques striataux dans la physiopathologie de la maladie de Parkinson : étude optogénétique, pharmacologique et comportementale
Ztaou, S. (2016) · theses.fr (ABES) · doi:10.70675/82c2ea24zaacdz49cfz88e0z86d5151777b4
Contribution des interneurones cholinergiques striataux aux déficits cognitifs de la maladie de Parkinson : approches optogénétique et comportementale chez la souris
Lhost, J. (2020) · theses.fr (ABES) · doi:10.70675/f950452bzadb5z4f7ez9635zf0f4496824a0
Association of morning plasma melatonin levels with chronotype, sleep disturbance, anxiety, and depression symptoms in adolescents with ADHD
Kuru, G., Ünver, H., Üner, E., & Haklar, G. (2026) · Sleep Medicine · doi:10.1016/j.sleep.2026.108949
Exploring the therapeutic potential of hesperidin nanoparticles, carbidopa-levodopa, or their combined administration in a rat model of reserpine-induced Parkinsonism
Amin, E. H. K., Ibrahim, I. H., Khadrawy, Y. A., & Mohammed, H. S. (2026) · Neuropharmacology · doi:10.1016/j.neuropharm.2026.111057
Actions of Dopamine on the Rat Striatal Cholinergic Interneurons
Aosaki, T. (2002) · Advances in behavioral biology · doi:10.1007/978-1-4615-0179-4_49

Authors: Di Chiara, G., Morelli, M., & Consolo, S.
Affiliations: University of Cagliari (IT)
Mario Negri Institute for Pharmacological Research (IT)
ORCID: Morelli, Micaela
Venue: Trends in Neurosciences
Publisher: Elsevier BV
Published: 1994-06
Volume: 17
Issue: 6
Pages: 228-233
ISSN: 0166-2236 (ISSN-L)
DOI: 10.1016/0166-2236(94)90005-1
OpenAlex: W1990162104
Semantic Scholar: 6620d60a424c6c77bf86292e9bd8b24706c6c57f
Cited by: 467
References: 72
Citations by year: 2026: 2 · 2025: 2 · 2024: 5 · 2023: 1 · 2022: 4 · 2021: 6 · 2020: 8 · 2019: 4 · 2018: 8 · 2017: 11 · 2016: 9 · 2015: 6 · 2014: 7 · 2013: 6 · 2012: 13
FWCI: 4.49
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Trends in Neurosciences (publishedVersion)
PubMed (publishedVersion)
UNICA IRIS Institutional Research Information System (University of Cagliari) (submittedVersion)
Topics: Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: striatum, acetylcholine, dopamine, NMDA receptor, cholinergic interneurons, medium spiny neurons, basal ganglia, neurotransmitter interactions, basal ganglia disorders, neuromodulation
MeSH terms: Acetylcholine, Animals, Corpus Striatum, Dopamine, Humans, Synaptic Transmission, Receptors, Dopamine, N-Methylaspartate, Neurotransmitter Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks